Related News
Sanofi sees mainland sales grow 8.8% in 2014
Print Edition
FRENCH pharmaceutical giant Sanofi said sales in China’s mainland grew 8.8 percent last year due to strong sales of cardiovascular and diabetes drugs.
The mainland’s sales growth nearly doubled the global increase of 4.9 percent.
Mainland sales were worth 1.6 billion euros (US$1.8 billion), compared with the global figure of 33.8 billion euros.
Sanofi hopes to continue to increase its market share for diabetes drugs and vaccine business as one of its main business growth engines in the coming year, Jean-Luc Lowinski, senior vice president of Sanofi Asia and president of Sanofi China, told a media briefing in Shanghai.
The company will also expand into lower-tier cities and counties by offering high-quality generic drugs at affordable prices, and Lowinski said Sanofi is open to discussions about launching new OTC products by collaborating with domestic drug companies.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
